Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.55 EUR | -0.38% | +4.33% | -5.52% |
Apr. 18 | FRESENIUS SE : Gets a Neutral rating from JP Morgan | ZD |
Apr. 17 | Lauterbach wants to press ahead with hospital reform despite differences | DP |
Chart calendar Fresenius SE & Co. KGaA
Upcoming events on Fresenius SE & Co. KGaA
Past events on Fresenius SE & Co. KGaA
2024-02-27 | UBS European Healthcare Conference |
2024-02-26 | Morgan Stanley European MedTech & Services Conference |
2024-02-25 | Roadshow |
2024-02-21 | Roadshow |
2024-02-21 07:30 am | Q4 2023 Earnings Call |
2024-02-20 | Q4 2023 Earnings Release |
2023-11-29 | Roadshow |
2023-11-28 | Roadshow |
2023-11-27 | Roadshow |
2023-11-02 | Roadshow |
2023-11-02 08:30 am | Q3 2023 Earnings Call |
2023-11-01 | Q3 2023 Earnings Release |
2023-08-02 07:30 am | Q2 2023 Earnings Call |
2023-08-01 | Q2 2023 Earnings Release |
2023-05-25 05:30 am | Capital Markets Day |
2023-05-17 | Ex-dividend day for final dividend |
2023-05-17 04:00 am | Annual General Meeting |
2023-05-09 | Roadshow |
2023-05-09 07:30 am | Q1 2023 Earnings Call |
2023-05-08 | Q1 2023 Earnings Release |
Past dividends on Fresenius SE & Co. KGaA
2023-05-17 | Annual 0.92 EUR |
2022-05-15 | Annual 0.26 EUR |
2022-05-15 | Annual 0.66 EUR |
2021-05-23 | Annual 0.88 EUR |
2020-08-30 | Annual 0.84 EUR |
2019-05-19 | Annual 0.8 EUR |
2018-05-20 | Annual 0.75 EUR |
2017-05-14 | Annual 0.62 EUR |
2016-05-15 | Annual 0.55 EUR |
2015-05-20 | 0.44 EUR |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 35 409 35 359 0.14% | 36 277 36 158 0.33% | 37 520 37 431 0.24% | 40 840 40 871 -0.08% | 22 299 22 421 -0.54% | 23 019 |
EBITDA Million EUR | Released Forecast Spread | 7 104 6 992 1.61% | 7 132 7 023 1.55% | 6 825 6 835 -0.14% | 6 294 6 665 -5.56% | 3 422 3 415 0.2% | 3 709 |
EBIT Million EUR | Released Forecast Spread | 4 599 4 588 0.23% | 4 612 4 544 1.5% | 4 252 4 219 0.79% | 4 004 3 880 3.19% | 2 262 2 228 1.55% | 2 432 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 3 912 3 889 0.6% | 3 726 3 853 -3.3% | 3 652 3 663 -0.3% | 2 814 3 100 -9.22% | 0,00 1 596 - | 1 980 |
Net income Million EUR | Released Forecast Spread | 1 883 1 823 3.3% | 1 707 1 735 -1.62% | 1 818 1 821 -0.18% | 1 372 1 576 -12.93% | 0,00 655 - | 1 421 |
EPS EUR | Released Forecast Spread | 3,38 3,34 1.16% | 3,06 3,17 -3.33% | 3,26 3,26 0.06% | 2,44 2,81 -13.07% | 0,00 1,57 - | 2,58 |
Announcement Date | 20/02/20 | 23/02/21 | 22/02/22 | 04/03/23 | 21/02/24 | - |
Quarterly results
Fiscal Period | December | 2020 S1 | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 18 055 18 050 0.03% | 18 230 18 079 0.84% | 9 966 9 845 1.23% | 9 720 9 475 2.58% | 10 018 9 996 0.22% | 10 459 10 242 2.12% | 10 643 10 789 -1.35% | 10 225 10 093 1.31% | 10 359 10 302 0.55% | 5 518 5 392 2.34% | 5 678 5 726 -0.83% | 5 711 | 5 781 | 5 720 | 5 863 |
EBITDA Million EUR | Released Forecast Spread | 1 868 1 746 6.99% | 1 658 1 500 10.53% | 1 658 1 635 1.41% | 1 585 1 500 5.67% | 1 649 1 478 11.57% | 634 | |||||||||
EBIT Million EUR | Released Forecast Spread | 2 248 | 2 039 2 020 0.94% | 1 166 1 121 4.03% | 996 901 10.58% | 1 003 1 088 -7.8% | 949 1 009 -5.9% | 1 052 1 080 -2.57% | 908 794 14.32% | 956 835 14.43% | 519 471 10.19% | 634 603 5.2% | 618 | 629 | 602 | 630 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 001 940 6.48% | 784 808 -3% | 729 | 551 778 -29.18% | |||||||||||
Net income Million EUR | Released Forecast Spread | 906 882 2.72% | 499 476 4.72% | 413 445 -7.09% | 383 474 -19.23% | 321 408 -21.28% | 255 522 -51.12% | 346 318 8.81% | 80,0 345 -76.79% | -406 371 -209.53% | 288 | 297 | 284 | 200 | ||
EPS EUR | Released Forecast Spread | 1,56 | 1,62 1,58 2.53% | 0,90 0,88 2.61% | 0,74 0,73 1.53% | 0,68 0,84 -19.08% | 0,57 0,73 -21.66% | 0,45 0,86 -47.91% | 0,61 0,56 8.93% | 0,15 0,57 -73.8% | -0,72 | 0,69 | 0,61 | 0,64 | 0,50 | 0,35 |
Announcement Date | 30/07/20 | 30/07/21 | 22/02/22 | 04/05/22 | 02/08/22 | 01/11/22 | 04/03/23 | 09/05/23 | 02/08/23 | 02/11/23 | 21/02/24 | - | - | - | - |
2024-04-21 | R&G PHARMASTUDIES CO., LTD.: Q1 2024 Earnings Release |
2024-04-21 | R&G PHARMASTUDIES CO., LTD.: Q4 2023 Earnings Release |
2024-04-23 06:45 am | QUEST DIAGNOSTICS INCORPORATED: Q1 2024 Earnings Release |
2024-04-23 07:00 am | OPTION CARE HEALTH, INC.: Q1 2024 Earnings Release |
2024-04-23 | EUROFINS SCIENTIFIC SE: Q1 2024 Sales and Revenue Release - Trading Update |
2024-04-23 | CHEMED CORPORATION: Q1 2024 Earnings Release |
2024-04-23 | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
2024-04-24 02:00 am | ATTENDO AB: Q1 2024 Earnings Release |
2024-04-24 | ACCOLADE, INC.: Q4 2024 Earnings Release |
2024-04-24 | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
Past sector events for Fresenius SE & Co. KGaA
2024-04-17 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q4 2023 Earnings Release |
2024-04-08 04:30 pm | SUMMERSET GROUP HOLDINGS LIMITED: Q1 2024 Sales and Revenue Release |
2024-04-02 | PT FAMON AWAL BROS SEDAYA TBK: Q4 2023 Earnings Release (Projected) |
2024-03-28 04:00 am | RHÖN-KLINIKUM AG: Q4 2023 Earnings Release |
2024-03-28 01:06 am | FUTURE CARE TRADING CO.: Q4 2023 Earnings Release |
2024-03-26 | DIAGNOSTICOS DA AMÉRICA S.A.: Q4 2023 Earnings Release |
2024-03-26 | JINXIN FERTILITY GROUP LIMITED: Q4 2023 Earnings Release |
2024-03-25 | REDE D'OR SÃO LUIZ S.A.: Q4 2023 Earnings Release |
2024-03-22 07:00 am | DENTALCORP HOLDINGS LTD.: Q4 2023 Earnings Release |
2024-03-21 07:00 am | WELL HEALTH TECHNOLOGIES CORP.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FRE Stock
- Calendar Fresenius SE & Co. KGaA